The 4th award ceremony for the 'Im Seong-ki Researcher Award' was held on 4th at the Hanmi Museum in Samcheong-dong, Seoul, established to honor the dedication and philosophy of Hanmi Pharmaceutical founder Im Seong-ki in new drug development. The recipient of the Daesang award, Professor Choi Hyeong-jin from Seoul National University's Department of Brain and Cognitive Sciences, received a plaque and a cash prize of 300 million won. Professors Lim Se-jin from Sungkyunkwan University School of Medicine and Lee Won-hwa from Sungkyunkwan University Department of Chemistry, recipients of the 'Young Researcher Award' for researchers under the age of 45, each received a plaque and a cash prize of 50 million won. Kim Chang-soo, chairman of the Im Seong-ki Foundation, noted, "We will continue to lay the foundation for the advancement of the fields of medicine and biotechnology, in line with Chairman Im's belief in creating better drugs to protect the lives and health of all people."
Samsung Biologics announced on the 6th that it has conducted various events for employees starting from the 24th of last month in celebration of International Women's Day on March 8. This initiative is part of efforts to establish an organizational culture that realizes gender equality. The events included special lectures for employees, a diversity & inclusion quiz event, and an official photo campaign for Women's Day. To support employees' work-life balance, Samsung Biologics operates an in-house daycare facility equipped with state-of-the-art childcare facilities, covering the entire cost excluding government subsidies. Parental leave is supported for up to two years per child, regardless of the employee's gender. This period is double the legal standard of one year. The utilization rate of parental leave by male employees stands at 90%.
Ciz Biotech announced on the 6th that it has been designated as an 'Excellent Corporate Research Institute' for the third consecutive time by the Ministry of Science and ICT. Ciz Biotech, a subsidiary of Daewoong Pharmaceutical, develops medical devices that assist in the regeneration of bones and cartilage. Notable achievements include the commercialization of the country's first porous ceramic bone graft material incorporating bone-forming proteins and the development of ceramic carrier-based materials suitable for high-risk spinal fusion surgeries. The designation of Excellent Corporate Research Institute is evaluated every three years, and Ciz Biotech has been recognized continuously through 2024, following designations in 2018 and 2021. Being an Excellent Corporate Research Institute provides benefits such as additional points in national research and development project participation, preferential designation as a military service special treatment corporation, and government awards.
Samjin Pharm unveiled a new advertising campaign for the domestic leading pain reliever 'Gevorin Tablet' for 2025. The core message of this advertisement is that it offers a smart solution for various pains and fevers with one Gevorin tablet, expressed in accordance with the AI assistant concept.
Enzychem Lifesciences announced on the 6th that it held an event themed 'Discovering a Healthy and Beautiful Me' at the Grand Hyatt Hotel in Seoul on the 3rd. This event was organized to lead the longevity revolution in response to the rapid rise of the senior market. Chairman Son Gi-young emphasized that a research team from the University of Connecticut successfully extended the lifespan of animals to the human equivalent of 130 years through inflammation regulation, predicting that the era of longevity will come through reduced inflammation. Through this event, Enzychem Lifesciences declared its vision of 'Healthy Longevity 130, Enzychem Lifesciences 3.0, Beautiful Life 3.0' and highlighted the importance of the senior market.
Korea Oganon announced on the 6th that it will conduct the 'Walk for Her Health' walking campaign for a month in celebration of International Women's Day on the 8th. The Walk for Her Health campaign is an event that marks its fourth year since Korea Oganon's launch, aimed at fostering healthy habits for women's health improvement. Anyone can participate, and by registering through the 'Big Walk' application, steps will be counted, allowing contributions of up to 30,000 steps a day. Upon achieving the target step count, funds will be distributed to vulnerable groups who need financial and medical support during pregnancy and childbirth.